REQUEST A DEMO
Total
USD $0.00
Search more companies

Shandong Sinobioway Biomedicine Co., Ltd. (China)

Main Activities: Basic Chemical Manufacturing
Full name: Shandong Sinobioway Biomedicine Co., Ltd. Profile Updated: November 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Shandong Sinobioway Biomedicine Co., Ltd. is a company located in Zibo, China. It is a major supplier of raw materials, specifically methyl formate and ethyl formate, to Zhejiang Xinhua Chemical Co., Ltd., a renowned global manufacturer of vitamins and ethyl formate. The company specializes in the research, development, production, and sales of pesticides and pharmaceutical intermediates such as methyl formate and ethyl formate. Shandong Sinobioway Biomedicine Co., Ltd. holds six invention patents and three utility model patents. It has also developed several non-patented technologies, particularly in the field of comprehensive utilization of hydrogen cyanide in acrylonitrile plant waste gas, where it leads domestically and achieves international advanced levels. The company has been recognized as a key high-tech enterprise under the Torch Program by the Ministry of Science and Technology. In 2009, it was jointly recognized as a high-tech enterprise by the Department of Science and Technology, the Department of Finance, the State Taxation Bureau, and the Local Taxation Bureau of Shandong Province. Additionally, the company has a provincial enterprise technology center. Leveraging its existing provincial enterprise technology center, Shandong Sinobioway Biomedicine Co., Ltd. continues to increase research and development investment to further develop and promote application technologies for the comprehensive utilization of hydrogen cyanide in acrylonitrile plant waste gas. This aims to optimize product structure, extend the industrial chain, enhance product added value, and strengthen sustainable development capabilities.

Headquarters
27th Floor, Qimei Building, Intersection of Xinhuan East Road and Ronger Road, Mashang Sub-district Office, Zhangdian District, Zibo City, Shandong Province
Zibo; Shandong; Postal Code: 255000

Contact Details: Purchase the Shandong Sinobioway Biomedicine Co., Ltd. report to view the information.

Website: http://www.sinobiowaymed.com.cn

Basic Information
Total Employees:
Purchase the Shandong Sinobioway Biomedicine Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Shandong Sinobioway Biomedicine Co., Ltd. report to view the information.
Registered Capital:
Purchase the Shandong Sinobioway Biomedicine Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Shandong Sinobioway Biomedicine Co., Ltd. report to view the information.
Incorporation Date:
January 18, 2000
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
11.19%
Purchase this report to view the information.
7.49%
Purchase this report to view the information.
4.85%
Purchase this report to view the information.
3.82%
Purchase this report to view the information.
3.64%
Subsidiaries
Jilin Weiming Tianren Traditional Chinese Medicine Technology Development Co., Ltd.
100%
Peking University Weiming (Hefei) Biopharmaceutical Co., Ltd.
100%
Peking University Weiming (Shanghai) Biopharmaceutical Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Shandong Sinobioway Biomedicine Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-6.99%
Total operating revenue
-22.55%
Operating profit (EBIT)
-39.54%
Net Profit (Loss) for the Period
-37.7%
Total assets
-17.98%
Total equity
-12.37%
Operating Profit Margin (ROS)
-4.62%
Net Profit Margin
-3.76%
Return on Equity (ROE)
-0.44%
Quick Ratio
7.67%
Cash Ratio
4.8%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?